Methylphenidate-prodrugs, processes of making and using the same
US9453037B2 · kind B2 · utility
9Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 1, 2015 |
| Grant date | Sep 27, 2016 |
| Priority date | — |
| Expiry date | Jun 1, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/06026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present technology is directed to prodrugs and compositions for the treatment of various diseases and/or disorders comprising methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof. In some embodiments, the conjugates further include at least one linker. The present technology also relates to the synthesis of methylphenidate, or methylphenidate derivatives, conjugated to at least one alcohol, amine, oxoacid, thiol, or derivatives thereof or combinations thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.